SCHEMBL30768416

SCHEMBL30768416

CON(C)C(=O)C(C)(OCc1cc(OCc2ccccc2)ccc1Br)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 3/20 0.41
▸ PTPN1 P18031 1/20 0.41
▸ LTB4R Q15722 1/20 0.40
▸ LTB4R2 Q9NPC1 1/20 0.40
▸ CACNA1B Q00975 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ ALOX5 P09917 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SRD5A2 P31213 1/20 0.38
▸ APP P05067 1/20 0.37
▸ MCHR1 Q99705 1/20 0.37
▸ EGFR P00533 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30769074 0.86 MAOB (0.47) MAOBBACE1L3MBTL1MEN1PKM
SCHEMBL30769131 0.85 MAOB (0.44) MAOBPTPN1CACNA1BBACE1NPC1
SCHEMBL30769423 0.78 RAB9A (0.47) MAOBLTB4RLTB4R2BACE1ALOX5
SCHEMBL2434378 0.71 MAOB (0.51) MAOBLTB4RLTB4R2ALOX5NPC1
SCHEMBL29925382 0.71 MAOB (0.54) MAOBALOX5L3MBTL1
SCHEMBL2133357 0.71 MAOB (0.54) MAOBALOX5L3MBTL1
SCHEMBL30768565 0.70 MAOB (0.43) MAOBPTPN1LTB4RLTB4R2BACE1
SCHEMBL30768454 0.70 FFAR1 (0.47) MAOBPTPN1BACE1ALOX5RAB9A
SCHEMBL30768939 0.69 PKM (0.55) MAOBLTB4RLTB4R2CACNA1BPKM
SCHEMBL31748829 0.69 MAOB (0.54) MAOBBACE1ALOX5MEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543871-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-04-30 — — EP disclosed
WO-2024006781-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-01-04 — — WO disclosed
Send feedback